Welcome to Betalin
+972 (52) 296 3130
nikolai@betalintherapeutics.com
Betalin - Logo
  • Home
  • Science
  • BetalinUK
  • News
  • Team
  • Collaborators
  • Contact

MEET THE TEAM

ADVISORY BOARD

Prof. Sidney Altman - NOBEL PRIZE WINNER

Professor Sidney Altman

NOBEL PRIZE WINNER

Nobel Prize winner in chemistry (1989) for his discoveries concerning the catalytic properties of RNA. Sterling Professor of Molecular, Cellular, and Developmental Biology and Chemistry at Yale University, specializes in molecular biology, he worked in renowned universities such as Harvard, Yale and Cambridge.

Prof. Arieh Warshel - NOBEL PRIZE WINNER

Professor Arieh Warshel

NOBEL PRIZE WINNER

Nobel Prize winner in chemistry (2013) for the development of multi-scale models for complex chemical systems. Prof. Warshel is a pioneer in computational studies on functional properties of biological molecules. Distinguished Professor of Chemistry and Biochemistry at University of Southern California in Los Angeles, USA, also worked in other renowned research institutes, such as Weizmann Institute of Science, Israel and the Laboratory of Molecular Biology at Cambridge, England.

Professor Stefan Bornstein

Director of the Centre for Internal Medicine and the Medical Clinic and Policlinic III at the University Hospital Carl Gustav Carus of the Technical University of Dresden as well as the medical faculty’s vice dean of international affairs and development and a member of the supervisory board of the University Hospital of Dresden. He is also the chair and honorary consultant for diabetes and endocrinology at King’s College London.

Prof. Gil Leibowitz

Professor Gil Lebiowitz

Senior Physician in the Endocrinology and Metabolism Service, Hadassah Medical Centre, Chairman of the Diabetes mellitus study centre in the Hebrew University.

PROF. EDUARDO MITRANI

Professor Eduardo Mitrani

INVENTOR OF BETALIN'S TECHNOLOGY

Professor of Developmental Biology at the Institute of Life Sciences at the Hebrew University of Jerusalem. Specializes in tissue engineering and adult tissue repair and regeneration.

BOARD OF DIRECTORS

Mr Joshua Hershcovich

CHAIRMAN AND FOUNDER

Mr. Hershcovich is the Chairman of the Board. He has vast hands-on experience in capital markets, mergers and acquisitions, and developing public companies from a financial and entrepreneurial perspective

Mr Shay Hershcovich

Mr. Hershcovich is an investment strategist with BA and MBA in Business Management, manages the company’s investment strategy and supports its Business Development activities

Mr Zohar Pinhasi

A former IT security intelligence officer for the Israeli military, he is the founder and CEO of MonsterCloud, a leader in ransomware removal and managed cyber security services backed by former FBI Deputy Director John Pistole. Mr. Pinhasi is an avid anti-ransomware advocate, providing cyber threat intelligence to some of the world’s top authorities, including The Federal Bureau of Investigation (FBI) and dozens of police departments and municipalities across the United States. 

Mr Cao Kun

Director of International Cooperation & Investment, Zhongguancun Medical Engineering & Translation Center (MTP). Mr. Kun specialized in the investment, financing, innovation management and business development of the advanced technology/product and SMEs in the field of healthcare/life science.

Mr Asaf Bartfled

Asaf Bartfeld has served as the Chief Executive and President of Delek Group, one of the largest Energy Companies in Israel since 2013.  Bartfeld retired from Delk Group at the end of 2019 after serving in various functions at the company for more than 30 years including the CFO of Delek Geoup. Bartfeld has held several senior positions at Delek Group during his time at the company, including Chairman or director in several Delek Group subsidiaries and affiliates including companies in the USA and England.

OUR TEAM

Dr Nikolai Kunicher

C E O

Dr. Kunicher has experience in Biotech R&D management and extensive knowledge of the IP management for companies such as, ARTSaVIT and AVA Biodefender. Served as Scientific Manager and Head of Business Development at Surgical Innovation and Technology Center, Hadassah Medical Center.

Dr Avi Treves

VP R&D

Dr. Treves has wide experience in translational research and clinical development in the fields of regenerative medicine and cell technologies and immuno-oncology as well as business development of biotech companies, commercialization of hospitals and academic institutes programs. Dr. Treves is co-author of more than 100 scientific publications and 10 patents. Dr. Treves was the founder and CEO of Hadasit Ltd. and Gamida-Cell Ltd (Nasdaq GMDA).

Dr Orit Goldman

HEAD OF R&D LABORATORY

Dr. Goldman has experience in both basic and clinical research, having worked in several top research institutes in France, USA and Israel. Dr. Goldman is an expert in basic and clinical stem cell research, embryology, molecular and cell biology, biochemistry, and translational and oncological research.

Dr Karina Durlacher-Betzer

SENIOR SCIENTIST

Dr. Durlacher- Betzer has extensive experience in cell culture, molecular biology and rodent research, in preclinical R&D. She also has experience in establishing and managing new experimental systems including immuno based in vitro and in vivo projects.

Ms Yaara Nester

PROJECT COORDINATOR & MEDICAL WRITER

Ms. Netser completed her undergraduate studies with honors in Biotechnology at Hadassah Academic College and her Masters in Cell and Developmental Biology at the Hebrew University of Jerusalem. She has extensive knowledge about drug development pathways including clinical studies and highly experienced in writing and submitting scientific files and applications.

Dr Bianca Patel

SCIENTIFIC PROJECT MANAGER (BETALINUK)

Dr. Patel completed her PhD in neuroendocrinology from the University of Leeds. She has a vast amount of in vivo and in vitro skills, with extensive knowledge in diabetes research. Dr. Patel has established Betalin Therapeutics first lab in the UK. 

Dr Vered Ben-Hur

TEAM LEADER & PROJECT MANAGER

Dr. Ben-Hur holds a Ph.D. in Biochemistry and Molecular Biology from the Hebrew University, Faculty of Medicine. Dr. Ben-Hur has over 10 years of research experience, mainly in the fields of cancer cell biology, molecular biology, Immuno-oncology and stem cell differentiation. She brings expertise in pre-clinical trials, cGMP regulations and development of drug and cell-based products with an emphasis on transition to manufacturing.

Ms Menucha Nadav

LAB TECHNICIAN

Ms. Nadav completed her undergraduate studies with honours in Biotechnology at Hadassah Academic College and her Masters in Cell and Developmental Biology at the Hebrew University of Jerusalem. She has extensive experience in various in vitro and in vivo methods. At Betalin, she has become proficient at stem cells and in vivo transplantation methods. 

Ms Chaya Spiegel

LAB TECHNICIAN

Ms. Spiegel has a BSc. In Biotechnology from Hadassah Academic college and a MSc. In Cell Biology from Hebrew University. She specializes in cell culture and molecular biology.

Mr Noam Mizrahi

LAB TECHNICIAN & QC

Mr. Noam Mizrahi is a dedicated engineer combining experience in GMP pharmaceutical manufacturing (e.g., biochemical processes, lyophilization) , quality control of raw and packaging materials according to regulations/ pharmacopeia, and utilities system qualification and monitoring

Mr Dima Puchinsky

LAB TECHNICIAN & QC

Mr. Puchinsky is an experienced technologist with BSc in biotechnology and MSc in biotechnology management. Experienced in sterile room working according to GMP conditions and the strict FDA rules at Teva.

© Betalin Therapeutics Ltd. All Rights Reserved
Betalin Therapeutics Ltd. is a preclinical stage company.
Betalin Therapeutics' products are not currently available for human use.